Format
Sealed research vial
Trust signal
COA-backed inventory
Metabolic & GLP-1 · Research grade
Lab-grade supply. Stocked in Australia.
From A$129.99
Select options below
Size
Select one
Select your preferred options to continue.
Fast AU dispatch, tracked delivery, and documentation-ready inventory.
Why labs buy from APL
High purity, consistent supply, and fast AU-wide dispatch.
Certificate of Analysis
COA library
Browse the current COA library and available product documentation.
Structural class
Cagrilintide is a long-acting amylin receptor analog structurally derived from human amylin (IAPP), with proline substitutions at positions 25 and 28 and a C18 fatty acid chain to prevent β-sheet aggregation and extend circulating half-life.
Pathways studied
Amylin receptors are obligate heterodimers of the calcitonin receptor (CTR) with one of three receptor activity-modifying proteins (RAMP1-3), generating AMY1, AMY2, and AMY3 subtypes with distinct ligand preferences. Cagrilintide binding triggers Gs-mediated cAMP accumulation and, depending on receptor subtype, Gq-linked IP3/DAG signalling, making subtype selectivity a relevant experimental variable. Wild-type human amylin (hIAPP) fibrillises rapidly in vitro at physiological concentrations — the proline substitutions in cagrilintide prevent β-sheet nucleation, providing a stable monomeric comparator for aggregation kinetics studies.
Typical research focus
Research panels frequently pair cagrilintide with GLP-1R agonists to examine whether AMY receptor co-stimulation modifies incretin-pathway outputs. Its stability advantage over native IAPP also makes it useful as a non-aggregating amylin reference in fibrillation inhibition screens.
For laboratory research use only. Not for human or veterinary use, and not for human consumption. Intended for in-vitro and pre-clinical research settings only.
How to read a certificate of analysis, what purity actually measures, and how research peptides are stored and independently verified.
The questions researchers ask most.
Every batch is independently tested by Janoshik Analytical. Each product links straight to the lab's own record, so you can check the exact purity figure yourself before you buy — nothing to take on trust.
Keep vials sealed, dry, and out of direct light. Lyophilised (freeze-dried) peptides are stable at -20 °C; once reconstituted, store as noted on the product label. Full handling notes sit on every product page.
Order by 2pm for same-day dispatch from our Melbourne warehouse, otherwise the next business day, with tracked delivery Australia-wide. No customs, no border delays — it's already in the country.
More in the full FAQ · Rated 4.6★ on Trustpilot
Researchers who bought Cagrilintide also stock these.
Amylin + GLP-1 fixed-ratio combination — dual-pathway assays
View
CJC-1295 + Ipamorelin — GHRH + GHSR co-stimulation assays
View
Stabilised GHRH analog — GH / IGF-1 pathway research
View
GLP-1R / GIPR / GcgR triple agonist — metabolic pathway research
ViewIt brings together 2 labelled variants: 5mg and 10mg, current pricing context, stock visibility, COA access, and internal links to related catalogue pages so a laboratory buyer can review the material from a single reference URL.
Cagrilintide is generally discussed as a long-acting amylin receptor analog structurally derived from human amylin (IAPP), with proline substitutions at positions 25 and 28 and a C18 fatty acid chain to prevent β-sheet aggregation and extend circulating half-life. The most relevant background is sequence behaviour, pathway or receptor context where documented, and analytical consistency under controlled laboratory conditions.
Use the label, COA, and internal SOPs as the primary guide. In general, store the material under controlled laboratory conditions, minimise avoidable environmental exposure, and keep variant tracking records current.
This page links the broader COA library when a product-specific document is not attached. Laboratories should use the published documentation set that is currently available for the listing.
No. The page should be interpreted strictly in a research and laboratory context. It does not provide dosage guidance, treatment claims, or human or animal use instructions.
